(San Antonio Business Journal) Among physicians who have partnered with medical device and pharmaceutical companies to parlay their intellectual property and subspecialty expertise resulting in improved patient care and outcomes are UT Medicine faculty, Charles Rockwood, M.D. (orthopaedics), Michael Wirth, M.D. (orthopaedics), Ralph DeFronzo, M.D.(internal medicine), and Robert Chilton, D.O. (cardiology).
“Roughly $2.6 billion in non-research-related payments in the form of royalties, licensing fees, speaking fees and travel and lodging reimbursements, among other forms of consideration, were made by drug and device developers to U.S. teaching hospitals and physicians in 2015.”
Read full article by W. Scott Bailey. October 28, 2016